Context-dependent roles of complement in cancer

LT Roumenina, MV Daugan, F Petitprez… - Nature Reviews …, 2019 - nature.com
The tumour microenvironment (TME) highly influences the growth and spread of tumours,
thus impacting the patient's clinical outcome. In this context, the complement system plays a …

YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1

SP Somasekharan, A El-Naggar, G Leprivier… - Journal of Cell …, 2015 - rupress.org
Under cell stress, global protein synthesis is inhibited to preserve energy. One mechanism is
to sequester and silence mRNAs in ribonucleoprotein complexes known as stress granules …

STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma

B Adane, G Alexe, BKA Seong, D Lu, EE Hwang… - Cancer cell, 2021 - cell.com
The core cohesin subunit STAG2 is recurrently mutated in Ewing sarcoma but its biological
role is less clear. Here, we demonstrate that cohesin complexes containing STAG2 occupy …

[HTML][HTML] Role of complement in regulating inflammation processes in renal and prostate cancers

GS Netti, R Franzin, A Stasi, F Spadaccino… - Cells, 2021 - mdpi.com
For decades, the complement system, the central pillar of innate immune response, was
recognized as a protective mechanism against cancer cells and the manipulation of …

BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells

DN Debruyne, R Dries, S Sengupta, D Seruggia, Y Gao… - Nature, 2019 - nature.com
The CCCTC-binding factor (CTCF), which anchors DNA loops that organize the genome into
structural domains, has a central role in gene control by facilitating or constraining …

Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis

P Savola, T Kelkka, HL Rajala, A Kuuliala… - Nature …, 2017 - nature.com
Somatic mutations contribute to tumorigenesis. Although these mutations occur in all
proliferating cells, their accumulation under non-malignant conditions, such as in …

Prognostic profiling of the immune cell microenvironment in Ewing s Sarcoma Family of Tumors

D Stahl, AJ Gentles, R Thiele, I Gütgemann - Oncoimmunology, 2019 - Taylor & Francis
ABSTRACT Ewing´ s Sarcoma Family of Tumors (ESFT) are clinically aggressive bone and
soft tissue tumors in children and young adults. Analysis of the immune tumor …

Therapeutic targeting the oncogenic driver EWSR1:: FLI1 in Ewing sarcoma through inhibition of the FACT complex

J Mo, K Tan, Y Dong, W Lu, F Liu, Y Mei, H Huang… - Oncogene, 2023 - nature.com
EWS/ETS fusion transcription factors, most commonly EWSR1:: FLI1, drives initiation and
progression of Ewing sarcoma (EwS). Even though direct targeting EWSR1:: FLI1 is a …

Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets

MC Baldauf, MF Orth, M Dallmayer, A Marchetto… - …, 2017 - pmc.ncbi.nlm.nih.gov
Ewing sarcoma is an undifferentiated small-round-cell sarcoma. Although molecular
detection of pathognomonic EWSR1-ETS fusions such as EWSR1-FLI1 enables definitive …

SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma

SW Tang, S Bilke, L Cao, J Murai, FG Sousa… - Clinical Cancer …, 2015 - aacrjournals.org
Purpose: SLFN11 was identified as a critical determinant of response to DNA-targeted
therapies by analyzing gene expression and drug sensitivity of NCI-60 and CCLE datasets …